InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Casten Richard S, Chief Financial Officer. Insider active across 1 company, notably Baudax Bio, Inc.. Aggregated, 4 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €76k. History available since 14 May 2021. The latest transaction was filed on 20 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
50,000 shares@ US$0.5128.6% of flowCommon StockSEC:0001192482-21-000673:0
Ideal exit: 17 May 2022 (T+270)
50,000 shares@ US$0.5128.6% of flowCommon StockSEC:0001192482-21-000673
Ideal exit: 17 May 2022 (T+270)
25,000 shares@ US$0.789921.4% of flowCommon StockSEC:0001192482-21-000437:0
Ideal exit: 8 Feb 2022 (T+270)
25,000 shares@ US$0.789921.4% of flowCommon StockSEC:0001192482-21-000437
Ideal exit: 8 Feb 2022 (T+270)
4 of 4 declarations
About Casten Richard S
Richard S. Casten serves as the Chief Financial Officer at Baudax Bio, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations. His role is crucial in ensuring the financial health of the organization.
